Investor mix
2 investors on record; lead investors include WTT investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Private equity | 1 | 50% |
Developer immunotherapies for the treatment of cancer
2 investors on record; lead investors include WTT investment.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 50% |
| Private equity | 1 | 50% |